Company Filing History:
Years Active: 2000-2001
Title: Silva Terdjanian: Innovator in Dopamine Receptor Research
Introduction
Silva Terdjanian is a notable inventor based in New Britain, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target dopamine receptors. With a total of 2 patents, Terdjanian's work is paving the way for advancements in therapeutic applications.
Latest Patents
Terdjanian's latest patents include innovative compounds such as benzylpiperazinyl and piperidinyl ethanone derivatives. These compounds are specifically designed as dopamine receptor subtype-specific ligands. The disclosed compounds are represented by the formula: ##STR1## or pharmaceutically acceptable addition salts thereof, wherein Y represents oxygen or sulfur, and Z is nitrogen or CH.
Career Highlights
Silva Terdjanian is currently associated with Neurogen Corporation, where he continues to push the boundaries of research in neuropharmacology. His work focuses on creating targeted therapies that can potentially improve the treatment of various neurological disorders.
Collaborations
Terdjanian collaborates with talented individuals such as Renata Xavier Kover and Jennifer N Tran, who contribute to the innovative environment at Neurogen Corporation.
Conclusion
Silva Terdjanian's contributions to the field of dopamine receptor research highlight his role as a key inventor in pharmacology. His ongoing work promises to lead to significant advancements in therapeutic options for neurological conditions.